Imaging guided drug discovery

The goal of the Clark Lab is to develop new therapies for cancer and autoimmune diseases.  The Clark Lab does this by learning from and leveraging positron emission tomography (PET) molecular imaging studies to discover critical pathways in these diseases, by using high-throughput screening efforts to identify new ways to target these pathways, and by further studying these pathways and inhibitors in cell culture and animal models.